179 related articles for article (PubMed ID: 10210147)
1. Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy-induced leukopenia.
Machiels JP; Govaerts AS; Guillaume T; Bayat B; Feyens AM; Lenoir E; Goeminne JC; Cole S; Deeley R; Caruso M; Bank A; Symann M; D'Hondt V
Hum Gene Ther; 1999 Mar; 10(5):801-11. PubMed ID: 10210147
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated gene transfer of the multidrug resistance-associated protein (MRP) cDNA protects cells from chemotherapeutic agents.
D'Hondt V; Caruso M; Bank A
Hum Gene Ther; 1997 Oct; 8(15):1745-51. PubMed ID: 9358024
[TBL] [Abstract][Full Text] [Related]
3. Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cells.
D'Hondt V; Symann M; Machiels JP
Curr Gene Ther; 2001 Nov; 1(4):359-66. PubMed ID: 12109062
[TBL] [Abstract][Full Text] [Related]
4. Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
Rappa G; Lorico A; Hildinger M; Fodstad Ø; Baum C
Hum Gene Ther; 2001 Sep; 12(14):1785-96. PubMed ID: 11560771
[TBL] [Abstract][Full Text] [Related]
5. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
6. Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs.
Omori F; Juopperi T; Chan CK; Chang YN; Phipps S; Nanji S; Zhao Y; Stewart AK; Dubé ID
J Hematother Stem Cell Res; 1999 Oct; 8(5):503-14. PubMed ID: 10791901
[TBL] [Abstract][Full Text] [Related]
7. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
Aksentijevich I; Cardarelli CO; Pastan I; Gottesman MM
Clin Cancer Res; 1996 Jun; 2(6):973-80. PubMed ID: 9816258
[TBL] [Abstract][Full Text] [Related]
8. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
[TBL] [Abstract][Full Text] [Related]
9. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
Guo CB; Li YC; Jin XQ
Cancer Chemother Pharmacol; 2006 Jul; 58(1):40-9. PubMed ID: 16284790
[TBL] [Abstract][Full Text] [Related]
10. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.
Licht T; Gottesman MM; Pastan I
Cytokines Mol Ther; 1995 Mar; 1(1):11-20. PubMed ID: 9384659
[TBL] [Abstract][Full Text] [Related]
11. Retroviral transfer of human MDR1 gene to hematopoietic cells: effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein.
Licht T; Aran JM; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
Hum Gene Ther; 1999 Sep; 10(13):2173-85. PubMed ID: 10498249
[TBL] [Abstract][Full Text] [Related]
12. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N',N"-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo.
Kobune M; Xu Y; Baum C; Kelley MR; Williams DA
Cancer Res; 2001 Jul; 61(13):5116-25. PubMed ID: 11431349
[TBL] [Abstract][Full Text] [Related]
13. Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells.
Salih SM
Fertil Steril; 2011 Mar; 95(4):1390-6.e1-6. PubMed ID: 21316663
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells.
Bertolini F; de Monte L; Corsini C; Lazzari L; Lauri E; Soligo D; Ward M; Bank A; Malavasi F
Br J Haematol; 1994 Oct; 88(2):318-24. PubMed ID: 7803276
[TBL] [Abstract][Full Text] [Related]
15. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
16. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.
Gao Z; Gao Z; Fields JZ; Boman BM
Anticancer Res; 1998; 18(4C):3073-6. PubMed ID: 9713512
[TBL] [Abstract][Full Text] [Related]
17. [A bicistronic retroviral vector containing MGMT and MDR1 drug resistance genes transfer into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance].
Wang JS; Sun DJ; Lin GW; Fei J
Shi Yan Sheng Wu Xue Bao; 2001 Sep; 34(3):227-33. PubMed ID: 12549225
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.
Takahashi S; Aiba K; Ito Y; Hatake K; Nakane M; Kobayashi T; Minowa S; Shibata H; Mitsuhashi J; Tsukahara S; Ishikawa E; Suzuki R; Tsuruo T; Sugimoto Y
Cancer Sci; 2007 Oct; 98(10):1609-16. PubMed ID: 17683514
[TBL] [Abstract][Full Text] [Related]
19. [Chemoprotection of transfer of multidrug resistance gene into human hematopoietic progenitor cell].
Pan L; Tong Y; Zhou S; Wu Y; Mao N; Yang X
Chin Med J (Engl); 2000 Jun; 113(6):536-9. PubMed ID: 11775875
[TBL] [Abstract][Full Text] [Related]
20. Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells.
Schiedlmeier B; Buss EC; Veldwijk MR; Zeller WJ; Fruehauf S
Hum Gene Ther; 1999 Jun; 10(9):1443-52. PubMed ID: 10395370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
